S Saidman

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival
    S Saidman
    Histocompatibility Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Transplant Proc 39:744-6. 2007
  2. ncbi Histocompatibility testing for highly sensitized transplant candidates
    S L Saidman
    Histocompatibility Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Transplant Proc 39:673-5. 2007
  3. ncbi Increasing the opportunity of live kidney donation by matching for two- and three-way exchanges
    Susan L Saidman
    Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
    Transplantation 81:773-82. 2006
  4. ncbi Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation
    B R Dey
    Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Blood Marrow Transplant 7:604-12. 2001
  5. ncbi Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries
    S Mauiyyedi
    Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Am Soc Nephrol 12:574-82. 2001
  6. ncbi Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen
    B R Dey
    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Bone Marrow Transplant 40:19-27. 2007
  7. ncbi The problem of late allograft loss in kidney transplantation
    F Cardarelli
    Renal and Transplantation Units, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Minerva Urol Nefrol 55:1-11. 2003
  8. ncbi Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts
    A B Farris
    Pathology Service, Massachusetts General Hospital MGH, Boston, MA, USA
    Am J Transplant 11:1464-77. 2011
  9. ncbi Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies
    Francesca Cardarelli
    Renal and Transplantation Units, Departments of Medicine and Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Am J Transplant 4:1352-6. 2004
  10. ncbi Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction
    Waichi Wong
    Transplantation Unit, Massachusetts General Hospital and Harvard Medical School, Boston, 02114, USA
    Clin Transplant 18:341-8. 2004

Collaborators

Detail Information

Publications16

  1. ncbi Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival
    S Saidman
    Histocompatibility Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Transplant Proc 39:744-6. 2007
    ..Additional studies focusing on the mechanism behind the apparent protection from the detrimental effects of antibody in such patients are needed...
  2. ncbi Histocompatibility testing for highly sensitized transplant candidates
    S L Saidman
    Histocompatibility Laboratory, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Transplant Proc 39:673-5. 2007
    ..Assays used for detecting panel-reactive and donor-specific HLA antibodies, including cytotoxicity, flow cytometry, and solid phase assays, are described in this review...
  3. ncbi Increasing the opportunity of live kidney donation by matching for two- and three-way exchanges
    Susan L Saidman
    Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
    Transplantation 81:773-82. 2006
    ....
  4. ncbi Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation
    B R Dey
    Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Blood Marrow Transplant 7:604-12. 2001
    ..Further follow-up and evaluation of additional patients are required to conclusively establish the role of this strategy in the treatment of hematologic malignancies after an autologous transplantation...
  5. ncbi Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries
    S Mauiyyedi
    Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    J Am Soc Nephrol 12:574-82. 2001
    ..C4d can be used to separate this group of CR from the nonspecific category of chronic allograft nephropathy and may have the potential to guide successful therapeutic intervention...
  6. ncbi Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen
    B R Dey
    Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Bone Marrow Transplant 40:19-27. 2007
    ..CD4 and CD8 T-cell recovery was faster in PBSC recipients. In PBSC recipients, a higher number of CD34+ cells was associated with increased rates of severe, grade III-IV acute GVHD...
  7. ncbi The problem of late allograft loss in kidney transplantation
    F Cardarelli
    Renal and Transplantation Units, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Minerva Urol Nefrol 55:1-11. 2003
    ..Evidence is now accumulating that new immunosuppressive regimens must control not only T cell but also B cell responses (i.e. limit antidonor antibody production) in order to prevent CR/CAN and improve long-term allograft survival...
  8. ncbi Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts
    A B Farris
    Pathology Service, Massachusetts General Hospital MGH, Boston, MA, USA
    Am J Transplant 11:1464-77. 2011
    ..Graft endothelium is the primary target of this process, attributable to as yet obscure mechanisms, arising during leukocyte recovery...
  9. ncbi Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies
    Francesca Cardarelli
    Renal and Transplantation Units, Departments of Medicine and Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Am J Transplant 4:1352-6. 2004
    ..In this study, LTRs receiving IFN did not have an increased frequency of anti-HLA antibodies. This may partially explain the safety of IFN previously reported in LTRs requiring antiviral therapy...
  10. ncbi Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction
    Waichi Wong
    Transplantation Unit, Massachusetts General Hospital and Harvard Medical School, Boston, 02114, USA
    Clin Transplant 18:341-8. 2004
    ..Hence, a reduction in CsA dosage in kidney transplant recipients (KTR) may improve long-term outcomes. We analyzed the effects of 50% CsA dose reduction on the CVD risk profile in stable KTR...
  11. ncbi Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification
    Shamila Mauiyyedi
    Pathology Service, Immunopathology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Am Soc Nephrol 13:779-87. 2002
    ..Because AHR has a distinct therapy and prognosis, we propose that it should be classified separately from ACR, with further sub-classification into AHR 1 (neutrophilic capillary involvement) and AHR 2 (arterial fibrinoid necrosis)...
  12. ncbi HLA-mismatched renal transplantation without maintenance immunosuppression
    Tatsuo Kawai
    Transplantation Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, USA
    N Engl J Med 358:353-61. 2008
    ....
  13. ncbi Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation
    Francesca Cardarelli
    Clinica Medica e Nefrologia, Universita degli Studi di Parma, Parma, Italy
    Transpl Int 18:532-40. 2005
    ..Anti-HLA antibodies were associated with a worse allograft function and in situ evidence of anti-donor humoral alloreactivity. Long-term RTR with an increase in creatinine could be screened for anti-HLA antibodies and C4d in biopsy...
  14. ncbi Allosensitization does not increase the risk of xenoreactivity to alpha1,3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists
    Banny S Wong
    Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, 02129, USA
    Transplantation 82:314-9. 2006
    ..We have investigated this question using sera from such patients on GalT-KO target cells...
  15. ncbi NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507
    Christian Koenecke
    Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02129, USA
    Exp Hematol 31:911-23. 2003
    ..Our data also raise questions about the applicability of observations made with NK cell clones to the bulk NK cell repertoire in humans...
  16. ncbi Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease
    Leo H Buhler
    Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA
    Transplantation 74:1405-9. 2002
    ....